Aslan Fred
- SEC CIK
- 0001909362
In the past year, 6 open-market sale filings worth $1.38M and no purchases.
Current role at each company
- ARTV Artiva Biotherapeutics, Inc.Chief Executive Officeras of Sep 15, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.38M
- 6 filings
- Net
- −$1.38M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Aslan Fred as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 (view filing)4:02 PM ET | Sep 8 | 1 day | Aslan FredChief Executive Officer | SSale | −23.4K | $10.92 | −$255.7K | −1.6%1.45M after | 10b5-1 |
| Sep 4, 2026 (view filing)4:02 PM ET | Sep 3 | 1 day | Aslan FredChief Executive Officer | SSale | −61.9K | $11.16 | −$690.4K | −4.0%1.47M after | |
| May 19, 2026 (view filing) | May 19 | Same day | Aslan FredChief Executive Officer | SSale | −27.1K | $9.01 | −$244.3K | −1.7%1.54M after | |
| Dec 15, 2025 (view filing) | Dec 15 | Same day | Aslan FredPresident and CEO | SSale | −3.19K | $6.00 | −$19.1K | −0.3%1.21M after | 10b5-1 |
| Nov 17, 2025 (view filing) | Nov 17 | Same day | Aslan FredPresident and CEO | SSale | −6.38K | $3.38 | −$21.5K | −1.8%344.0K after | 10b5-1 |
| Oct 17, 2025 (view filing) | Oct 17 | Same day | Aslan FredPresident and CEO | SSale | −25.5K | $6.00 | −$153.0K | −6.7%356.7K after | 10b5-1 |
| Aug 18, 2025 (view filing) | Aug 15 | 3 days | Aslan FredPresident and CEO | SSale | −25.5K | $2.73 | −$69.6K | −6.2%386.7K after | 10b5-1 |